Somatropin (HGH) 36 IU

Dual-Chamber Pen

Somatropin (HGH) 36 IU Peptide Pen contains recombinant human growth hormone, identical in amino-acid sequence to naturally occurring HGH. It has been extensively studied for its role in growth, tissue repair and recovery, protein synthesis, body composition and fat metabolism.

Through the GH–IGF-1 pathway, Somatropin is closely associated with the growth and renewal of muscle, bone and connective tissue, making it an important compound in research into recovery and metabolic regulation.

PCP’s proprietary Dual-Chamber Technology keeps the lyophilised Somatropin separate from the sterile diluent until activation.

For laboratory research use only. Not intended for human or veterinary use.

Strength 36 IU

2.090,00 CZK

Sale Sold out

Taxes included. Shipping calculated at checkout.

Fast, Tracked Shipping

Secure Checkout

COA Available With Lot

Expert Support

Product Details

The Somatropin (HGH) Dual-Chamber Research Pen is supplied as a complete, preloaded system containing lyophilised Somatropin and sterile diluent in two physically separated chambers. The components remain unmixed throughout storage and transport and are combined only when the pen is activated for laboratory preparation.

The 36 IU strength is clearly identified and presented in protective packaging for straightforward product selection, handling and storage within qualified research environments.

Product highlights:

Proprietary dual-chamber configuration
Lyophilised Somatropin and sterile diluent contained separately
Components remain unmixed until activation
Available in 36 IU strength
Provides 100 dial units in total
One complete dual-chamber research pen
Five 32G × 4 mm needle tips included
Protective packaging for storage and transport
Certificate of Analysis (COA) available

Technical specifications, storage conditions and handling guidance are provided separately to support accurate product identification and responsible laboratory use.

Technical Specifications

Intended Use: For laboratory research use only. Not for human or veterinary use.
Shipping Condition: Securely packaged for transport with tracked delivery.
Storage Temperature: Unopened/unmixed: store refrigerated at 2–8°C. After mixing: store refrigerated at 2–8°C. Do not freeze. Protect from light.
Presentation: One pre-filled double-chamber research pen containing unmixed components, supplied with three 32G × 4 mm needle tips
Form: Lyophilized peptide powder and diluent maintained in separate chambers
Compound Identity: Compound: Somatropin (recombinant human growth hormone; rhGH)

Compound type: Recombinant 191-amino-acid polypeptide corresponding in sequence to endogenous human growth hormone

Research classification: Growth hormone receptor (GHR) agonist investigated in connection with receptor pharmacology, JAK2–STAT5 signalling, endocrine regulation, cellular growth and metabolic pathways

Refer to the applicable product and batch documentation for verified analytical and chemical identity information.

Pen Specifications

Each pen contains a 1 mL cartridge. The reference tables show the IU value represented by one dial unit and by the listed dial settings.

Pen Specifications
Pen strength	Cartridge	1 dial unit
36 IU	1 mL	0.36 IU

Dial-Unit Conversion Reference

The table shows the amount represented by each listed dial setting for the available pen strengths.

Dial-unit reference by pen strength
Dial units	36 IU
1	0.36 IU
4	1.44 IU
5	1.8 IU
10	3.6 IU
20	7.2 IU
40	14.4 IU

Somatropin mass equivalence: 3 IU corresponds to 1 mg. Values are provided as technical product information for laboratory research only.

Research-use information: Dial-unit values are provided solely for product identification, quantitative laboratory planning and documentation. They are not administration or clinical dosing instructions.

Storage & Handling

Recommended storage: Unopened/unmixed: store refrigerated at 2–8°C. After mixing: store refrigerated at 2–8°C. Do not freeze. Protect from light.

Protect the product from light and moisture and minimise unnecessary exposure to room temperature.

Complete storage and handling guidance is provided in the product information section below.

Research Use Only

All Pencell Peptide (PCP) products are supplied exclusively for laboratory research use by qualified professionals. They are not intended for human or veterinary use, consumption, personal use, medical, therapeutic, or diagnostic applications. Customers are responsible for lawful purchase, storage, handling, use, and disposal in accordance with applicable regulations and approved laboratory procedures.

View full details

Protected by Design

Peptide and diluent remain separate until preparation

≥98% Purity

HPLC verified for research grade quality

Controlled Conditions

Prepared with a focus on consistency and research quality

Certificate of Analysis

Provided with Every Lot

Scientific Overview

Scientific Background

Somatropin is a recombinant form of human growth hormone composed of 191 amino acids in the same sequence as naturally occurring human growth hormone. This sequence determines its three-dimensional structure and allows it to interact with the growth hormone receptor (GHR).

Somatropin acts as a GHR agonist, activating signalling pathways involved in growth, tissue development and metabolic regulation. One of the most important is JAK2–STAT5 signalling, which influences gene expression and stimulates production of insulin-like growth factor 1 (IGF-1).

The GH–IGF-1 pathway helps explain many of the biological processes associated with growth hormone, including cellular growth, protein synthesis, muscle and bone development, connective-tissue biology and fat metabolism. This makes Somatropin particularly useful for studying how receptor activation translates into wider physiological responses.

Research across cellular, preclinical and clinical models continues to expand understanding of growth-hormone biology, tissue development, endocrine signalling and metabolic regulation.

This information is provided as general scientific background for laboratory research purposes.

Somatropin has been extensively studied for its activity at the growth hormone receptor (GHR) and its influence on growth, tissue repair, protein synthesis and metabolic regulation. Activation of GHR also stimulates production of IGF-1, an important mediator of many growth-hormone-related processes.

Researchers continue to investigate how the GH–IGF-1 pathway influences muscle, bone and connective tissue, cellular growth, fat metabolism and recovery-related processes, alongside intracellular pathways such as JAK2–STAT5 signalling.

Current areas of scientific investigation include:

JAK2–STAT5 Signalling (Somatropin)

Investigation of intracellular JAK2–STAT5 pathway activation, transcriptional regulation and associated cellular responses following growth hormone receptor engagement.
Growth Hormone Receptor Pharmacology (Somatropin)

Evaluation of Somatropin’s interaction with the growth hormone receptor, including receptor binding, activation and downstream signalling under controlled experimental conditions.
Endocrine Signalling

Investigation of peptide-mediated receptor activity and its role in hormonal communication, endocrine regulation and coordination between biological systems.
Metabolic Signalling

Research into molecular pathways involved in glucose regulation, energy balance, nutrient-responsive signalling, lipid metabolism and broader metabolic processes.
Peptide Structure & Activity

Comparative investigation of how the distinct amino-acid sequences and molecular characteristics of BPC-157 and TB-500 relate to their observed activity in controlled experimental models.
GH–IGF-1 Axis (Somatropin)

Study of the relationship between growth hormone receptor activation, insulin-like growth factor 1 expression and broader endocrine signalling within the GH–IGF-1 axis.
Comparative Growth-Hormone Research (Somatropin)

Comparative evaluation of Somatropin alongside endogenous growth hormone, recombinant preparations and modified growth-hormone compounds to investigate differences in receptor engagement, molecular characteristics and functional activity.

Studies of Somatropin have helped establish how growth hormone influences tissue growth and repair, protein synthesis, body composition and fat metabolism. Many of these effects are mediated through IGF-1, which is produced in response to growth hormone receptor activation and plays an important role in muscle, bone and connective-tissue biology.

Research continues to examine how the GH–IGF-1 pathway affects cellular growth and regeneration, as well as how growth hormone influences protein and lipid metabolism. At the cellular level, pathways including JAK2–STAT5 signalling and gene expression help researchers understand how activation of the growth hormone receptor produces these wider biological responses.

Together, these findings continue to build understanding of the relationship between growth hormone signalling, tissue development, recovery and metabolic regulation.

For laboratory research purposes only. Not intended for human or veterinary use.

Important Notice Research Use Only View complete notice

All products supplied by Pencell Peptide (PCP), including its dual-chamber peptide research pens, are intended strictly for laboratory research purposes only.

These products are not intended for human or animal consumption, medical or veterinary use, therapeutic applications, diagnostic procedures or any other clinical purpose.

Customers are responsible for complying with all applicable laws, regulations and institutional requirements governing the purchase, possession, handling, storage and use of peptide research materials.

Read the complete Research Use Only notice .

Item added to your cart

Somatropin (HGH) 36 IU